Cargando…

Long-term secular trends in dermatomyositis and polymyositis mortality in the USA from 1981 to 2020 according to underlying and multiple cause of death mortality data

BACKGROUND: People with dermatomyositis (DM) or polymyositis (PM) often die from cancer, pulmonary, cardiac complications, or infections. In such cases, DM or PM might not be designated as the underlying cause of death (UCD) for mortality tabulation. In this study, we investigated DM/PM mortality tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiao, Pengyan, Guo, Qianyu, Gao, Jinfang, Ma, Dan, Liu, Sumiao, Gao, Xiang, Lu, Tsung-Hsueh, Zhang, Liyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9887902/
https://www.ncbi.nlm.nih.gov/pubmed/36721230
http://dx.doi.org/10.1186/s13075-022-02963-y
_version_ 1784880432156770304
author Qiao, Pengyan
Guo, Qianyu
Gao, Jinfang
Ma, Dan
Liu, Sumiao
Gao, Xiang
Lu, Tsung-Hsueh
Zhang, Liyun
author_facet Qiao, Pengyan
Guo, Qianyu
Gao, Jinfang
Ma, Dan
Liu, Sumiao
Gao, Xiang
Lu, Tsung-Hsueh
Zhang, Liyun
author_sort Qiao, Pengyan
collection PubMed
description BACKGROUND: People with dermatomyositis (DM) or polymyositis (PM) often die from cancer, pulmonary, cardiac complications, or infections. In such cases, DM or PM might not be designated as the underlying cause of death (UCD) for mortality tabulation. In this study, we investigated DM/PM mortality trends in the USA from 1981 to 2020 with respect to UCD and multiple causes of death (MCD) data. METHODS: We used the MCD data to identify all deaths with DM or PM mentioned anywhere on the death certificate and as the UCD in the USA from 1981–1982 to 2019–2020. We calculated age-adjusted mortality rates (AAMRs) and annual percentage changes (APCs) based on joinpoint regression analysis. RESULTS: We identified 12,249 (3985 with DM and 7097 with PM) and 23,608 (8264 with DM and 15,344 with PM) people who died between 1981 and 2020 according to the UCD and MCD data, respectively. For DM, the APC was − 6.7% (from 1981–1982 to 1985–1986), − 0.1% (from 1985–1986 to 2003–2004), and − 1.9% (from 2003–2004 to 2019–2020) according UCD and was − 1.2% (from 1981–1982 to 2003–2004), − 2.5% (from 2003–2004 to 2015–2016), and 2.8% (from 2015–2016 to 2019–2020) according MCD. For PM, the APC was 1.9% (from 1981–1982 to 1989–1990), − 2.3% (from 1989–1990 to 2005–2006), and − 5.2% (from 2005–2006 to 2019–2020) according UCD and was 1.3% (from 1981–1982 to 1991–1992) and − 4.1% (from 1991–1992 to 2019–2020) according MCD. CONCLUSION: We identified two times as many DM/PM deaths using the MCD as those identified using the UCD. Similar downward DM/PM mortality trends were noted according to UCD and MCD. However, the year of significant decline in PM mortality was about 10 years earlier according to MCD than those according to UCD.
format Online
Article
Text
id pubmed-9887902
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-98879022023-02-01 Long-term secular trends in dermatomyositis and polymyositis mortality in the USA from 1981 to 2020 according to underlying and multiple cause of death mortality data Qiao, Pengyan Guo, Qianyu Gao, Jinfang Ma, Dan Liu, Sumiao Gao, Xiang Lu, Tsung-Hsueh Zhang, Liyun Arthritis Res Ther Research BACKGROUND: People with dermatomyositis (DM) or polymyositis (PM) often die from cancer, pulmonary, cardiac complications, or infections. In such cases, DM or PM might not be designated as the underlying cause of death (UCD) for mortality tabulation. In this study, we investigated DM/PM mortality trends in the USA from 1981 to 2020 with respect to UCD and multiple causes of death (MCD) data. METHODS: We used the MCD data to identify all deaths with DM or PM mentioned anywhere on the death certificate and as the UCD in the USA from 1981–1982 to 2019–2020. We calculated age-adjusted mortality rates (AAMRs) and annual percentage changes (APCs) based on joinpoint regression analysis. RESULTS: We identified 12,249 (3985 with DM and 7097 with PM) and 23,608 (8264 with DM and 15,344 with PM) people who died between 1981 and 2020 according to the UCD and MCD data, respectively. For DM, the APC was − 6.7% (from 1981–1982 to 1985–1986), − 0.1% (from 1985–1986 to 2003–2004), and − 1.9% (from 2003–2004 to 2019–2020) according UCD and was − 1.2% (from 1981–1982 to 2003–2004), − 2.5% (from 2003–2004 to 2015–2016), and 2.8% (from 2015–2016 to 2019–2020) according MCD. For PM, the APC was 1.9% (from 1981–1982 to 1989–1990), − 2.3% (from 1989–1990 to 2005–2006), and − 5.2% (from 2005–2006 to 2019–2020) according UCD and was 1.3% (from 1981–1982 to 1991–1992) and − 4.1% (from 1991–1992 to 2019–2020) according MCD. CONCLUSION: We identified two times as many DM/PM deaths using the MCD as those identified using the UCD. Similar downward DM/PM mortality trends were noted according to UCD and MCD. However, the year of significant decline in PM mortality was about 10 years earlier according to MCD than those according to UCD. BioMed Central 2023-01-31 2023 /pmc/articles/PMC9887902/ /pubmed/36721230 http://dx.doi.org/10.1186/s13075-022-02963-y Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Qiao, Pengyan
Guo, Qianyu
Gao, Jinfang
Ma, Dan
Liu, Sumiao
Gao, Xiang
Lu, Tsung-Hsueh
Zhang, Liyun
Long-term secular trends in dermatomyositis and polymyositis mortality in the USA from 1981 to 2020 according to underlying and multiple cause of death mortality data
title Long-term secular trends in dermatomyositis and polymyositis mortality in the USA from 1981 to 2020 according to underlying and multiple cause of death mortality data
title_full Long-term secular trends in dermatomyositis and polymyositis mortality in the USA from 1981 to 2020 according to underlying and multiple cause of death mortality data
title_fullStr Long-term secular trends in dermatomyositis and polymyositis mortality in the USA from 1981 to 2020 according to underlying and multiple cause of death mortality data
title_full_unstemmed Long-term secular trends in dermatomyositis and polymyositis mortality in the USA from 1981 to 2020 according to underlying and multiple cause of death mortality data
title_short Long-term secular trends in dermatomyositis and polymyositis mortality in the USA from 1981 to 2020 according to underlying and multiple cause of death mortality data
title_sort long-term secular trends in dermatomyositis and polymyositis mortality in the usa from 1981 to 2020 according to underlying and multiple cause of death mortality data
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9887902/
https://www.ncbi.nlm.nih.gov/pubmed/36721230
http://dx.doi.org/10.1186/s13075-022-02963-y
work_keys_str_mv AT qiaopengyan longtermseculartrendsindermatomyositisandpolymyositismortalityintheusafrom1981to2020accordingtounderlyingandmultiplecauseofdeathmortalitydata
AT guoqianyu longtermseculartrendsindermatomyositisandpolymyositismortalityintheusafrom1981to2020accordingtounderlyingandmultiplecauseofdeathmortalitydata
AT gaojinfang longtermseculartrendsindermatomyositisandpolymyositismortalityintheusafrom1981to2020accordingtounderlyingandmultiplecauseofdeathmortalitydata
AT madan longtermseculartrendsindermatomyositisandpolymyositismortalityintheusafrom1981to2020accordingtounderlyingandmultiplecauseofdeathmortalitydata
AT liusumiao longtermseculartrendsindermatomyositisandpolymyositismortalityintheusafrom1981to2020accordingtounderlyingandmultiplecauseofdeathmortalitydata
AT gaoxiang longtermseculartrendsindermatomyositisandpolymyositismortalityintheusafrom1981to2020accordingtounderlyingandmultiplecauseofdeathmortalitydata
AT lutsunghsueh longtermseculartrendsindermatomyositisandpolymyositismortalityintheusafrom1981to2020accordingtounderlyingandmultiplecauseofdeathmortalitydata
AT zhangliyun longtermseculartrendsindermatomyositisandpolymyositismortalityintheusafrom1981to2020accordingtounderlyingandmultiplecauseofdeathmortalitydata